Foreign investment has accelerated the expansion of India’s rapidly growing hospital sector, bringing modern medical facilities, new hospitals and advanced equipment. However, the influx of capital has also intensified a dispute between health insurers and private hospitals over rising treatment costs.
Insurers allege that pressure to deliver higher returns on investments is encouraging some private hospitals to charge patients more and perform expensive procedures that may not always be medically necessary. According to data from consultancy firm EY, global private equity funds including Blackstone, KKR, TPG, Temasek and General Atlantic have invested nearly ₹95,000 crore in Indian hospitals over the past five years. The investment has helped expand hospital networks and encouraged consolidation across the sector. Large hospital groups have added new facilities, increased bed capacity and invested in advanced medical technologies.
However, health insurers have raised serious concerns over the financial impact of this transformation. They allege that the pressure on private hospitals to generate higher returns for investors is contributing to an increase in treatment costs. According to insurers, expensive technologies and procedures are sometimes being used in ways that increase patient bills, even when their clinical benefits compared with conventional treatment may not always be significant.
FCRF Launches CP-FRM to Build India’s Next Generation of Fraud Risk Professionals
Robotic surgery has emerged as one of the major points of contention. S. Prakash, CEO of the Health Ecosystem at the General Insurance Council, has said that treatment at private hospitals can cost five to ten times more than at government hospitals in several cases. According to him, the cost of capital flowing into private healthcare is ultimately being passed on to patients through higher medical bills.
Bhavatosh Mishra, COO of Niva Bupa Health Insurance, has also accused hospitals of steering patients towards robotic surgery. He said robotic procedures can cost several times more than conventional surgery, while the clinical outcomes may not differ significantly in many cases. Supporters of robotic surgery, however, point to potential benefits such as greater precision, reduced blood loss and faster recovery in selected procedures. The medical necessity of the technology therefore needs to be assessed on a case-by-case basis.
The dispute has raised particular concerns over what is often described as India’s “missing middle”. According to Animesh Das of Acko, this group includes millions of middle-class families who are above the eligibility threshold for government health schemes but may not have sufficient financial capacity to absorb steadily rising private healthcare costs. Increasing medical expenses and health insurance premiums could put additional financial pressure on these households.
The shortage of hospital infrastructure is one of the factors attracting investment into the Indian healthcare sector. Available figures indicate that India has around 1.3 hospital beds per 1,000 people, considerably lower than the average in many developed countries. Private equity investors have viewed this gap between demand and available capacity as an opportunity to expand hospital infrastructure.
However, investment has not been limited to increasing the number of beds. Private equity-backed hospital groups have also focused on high-revenue specialties such as cardiac surgery, oncology and organ transplantation. These areas generally involve expensive procedures and can generate significantly higher revenue for hospitals than routine medical services.
Joseph Benaven, managing director of Kanate Hospitals in Kerala and former president of the state unit of the Indian Medical Association, said the transformation in Indian healthcare has taken place not only inside operating theatres but also in hospital boardrooms. According to him, doctors and hospitals are increasingly being assessed not just on patient care but also on metrics such as revenue generated per bed and returns delivered to investors.
The growing presence of foreign capital has increased the availability of funding for hospital expansion, modern equipment and advanced medical services. At the same time, it has brought the affordability of healthcare into sharper focus. The growing dispute between insurers and hospitals reflects a larger question facing India’s healthcare system: how to balance investment, technological advancement and reasonable returns with the need to keep essential medical treatment affordable for patients, particularly the country’s large middle-class population.
Follow for daily updates on cybercrime, corporate fraud, DFIR, hacking, investigations, and digital forensics
